The Advisory Board will meet annually to review the implementation of the programme and to specifically assess how successfully the programme activities are aiding the professional development of the mobilized fellows.
The Chair of the Advisory Board will be Professor Mark Caulfield, the Director of WHRI and Centre Lead for Clinical Pharmacology in London (United Kingdom).
Professor Vera Popovic, Head of Neuroendocrine Unit at the University Clinical Center in Belgrade (Serbia) will act as Scientific Advisor.
Dr. Peter Ruifrok, Managing Director of Stadex in The Netherlands, will act as Innovation EU Affairs Advisor.
Richard Corliss, Chair of the Brussels New Generation group and Senior Director at Cambre Public Relations and Public Affairs, will act as Strategic Dissemination Advisor.